戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 to the impairment of QOL in individuals with neurofibromatosis 1.
2       Lack of expression of neurofibromin in neurofibromatosis 1 and its lethal derivative, malignant
3                                              Neurofibromatosis 1 and neurofibromatosis 2 are autosoma
4 was to determine the diagnostic criteria for neurofibromatosis 1 and neurofibromatosis 2, recommendat
5 inical impact on the neurocutaneous diseases neurofibromatosis 1 and neurofibromatosis 2.
6 ete understanding of the molecular bases for neurofibromatosis 1 and neurofibromatosis 2.
7  diagnosis and treatment of individuals with neurofibromatosis 1 and neurofibromatosis 2.
8 ysfunction is among the hallmark symptoms of Neurofibromatosis 1, and accordingly, loss of the Drosop
9               Tuberous sclerosis complex and neurofibromatosis 1 are of special interest to the neuro
10  expression profiles of six sporadic and two neurofibromatosis 1-associated PAs with other tissues an
11 ession was also determined in KIT mutant and neurofibromatosis-1-associated GIST, and complex II acti
12                         It is now known that neurofibromatosis-1-associated GISTs are SDHB-positive,
13 ated with neurofibromatosis 1 show a loss of neurofibromatosis 1 expression and high levels of Ras, b
14 n EVH [Ena/Vasp homology] domain 1) and NF1 (neurofibromatosis 1) genes underlie clinically related h
15       New data suggest that individuals with neurofibromatosis 1 have a 10% lifetime risk of developi
16                                              Neurofibromatosis 1 is a hereditary syndrome characteriz
17  in SDHB (n = 2), SDHD (n = 3), RET (n = 5), neurofibromatosis 1 (n = 1), and myc-associated factor X
18                                The genes for neurofibromatosis 1, neurofibromatosis 2, and one of two
19                                              Neurofibromatosis 1, neurofibromatosis 2, and tuberous s
20  negative Ras-MAPK-ERK regulator linked to a neurofibromatosis 1 (NF-1)-like human syndrome; however,
21 viduals with two inherited cancer syndromes, neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2),
22                                Patients with neurofibromatosis 1 (NF1) are predisposed to develop mul
23     Fifteen per cent of individuals with the neurofibromatosis 1 (NF1) cancer predisposition syndrome
24                   The tumour-suppressor gene Neurofibromatosis 1 (Nf1) encodes a Ras-specific GTPase
25  We have identified a protein isoform of the neurofibromatosis 1 (NF1) gene (neurofibromin) containin
26                                          The neurofibromatosis 1 (NF1) gene encodes a cytoplasmic pro
27                                          The neurofibromatosis 1 (NF1) gene has been implicated in as
28 gested that one of the targets of MMR is the neurofibromatosis 1 (NF1) gene.
29 he phosphatase and tensin homolog (Pten) and neurofibromatosis 1 (Nf1) genes recently were found to b
30                    Individuals affected with neurofibromatosis 1 (NF1) harbor increased numbers of GF
31                                Historically, neurofibromatosis 1 (NF1) has been inextricably linked w
32 arning to rut mutants, whereas expression of Neurofibromatosis 1 (NF1) in alpha/beta neurons is suffi
33                            Whereas biallelic neurofibromatosis 1 (NF1) inactivation is observed in NF
34 of children develop PA in the context of the neurofibromatosis 1 (NF1) inherited tumor predisposition
35                         Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome devel
36                                              Neurofibromatosis 1 (NF1) is a common inherited disease
37                                     Although neurofibromatosis 1 (NF1) is a relatively common autosom
38                                              Neurofibromatosis 1 (NF1) is a single-gene disorder asso
39                                              Neurofibromatosis 1 (NF1) is an autosomal dominant tumor
40                                              Neurofibromatosis 1 (NF1) is caused by mutations in the
41 aches to mutation detection in mRNA from the neurofibromatosis 1 (NF1) locus have required the PCR am
42                            >U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA)
43                Individuals affected with the neurofibromatosis 1 (NF1) tumor predisposition syndrome
44                         Individuals with the neurofibromatosis 1 (NF1) tumor predisposition syndrome
45                                              Neurofibromatosis 1 (NF1), also known as von Recklinghau
46 c nerve gliomas) are closely associated with neurofibromatosis 1 (NF1), and allelic losses of the NF1
47 uals with the tumor predisposition syndrome, neurofibromatosis 1 (NF1), are prone to development of n
48 the inherited tumor predisposition syndrome, neurofibromatosis 1 (NF1), are prone to the development
49 dren with the tumor predisposition syndrome, neurofibromatosis 1 (NF1), develop optic pathway gliomas
50 s using cells derived from a murine model of neurofibromatosis 1 (NF1), Yang et al. dissect the molec
51                         Individuals with the neurofibromatosis 1 (NF1)-inherited tumor predisposition
52                                Children with neurofibromatosis-1 (NF1) are at risk for developing num
53                       In this study, we used neurofibromatosis-1 (NF1) as a model system to elucidate
54                          Inactivation of the neurofibromatosis-1 (NF1) gene de-regulates RAS and coop
55                     To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain develo
56         In Drosophila, null mutations of the neurofibromatosis-1 (Nf1) gene produce abnormalities of
57 aracterized by inactivating mutations of the Neurofibromatosis-1 (NF1) gene that predisposes these pa
58 ious studies from our laboratories have used neurofibromatosis-1 (NF1) genetically engineered mouse (
59       We investigated the pathophysiology of neurofibromatosis-1 (NF1) in Drosophila melanogaster by
60 ommon clinical problems in children with the neurofibromatosis-1 (NF1) inherited cancer syndrome.
61                                              Neurofibromatosis-1 (NF1) is a common tumor predispositi
62 s, T cells, and microglia interact to govern Neurofibromatosis-1 (NF1) low-grade glioma (LGG) growth.
63 ma resulting from either inactivation of the neurofibromatosis-1 (Nf1) tumor suppressor gene or const
64   In this regard, mutational inactivation of neurofibromatosis-1 (NF1), tuberous sclerosis complex (T
65  models of the tumor predisposition syndrome Neurofibromatosis-1 (NF1), with different propensities t
66 somal dominant human disorder that resembles Neurofibromatosis-1 (NF1).
67 ients and are a major contributing factor to neurofibromatosis-1 patient mortality and morbidity.
68 yndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and
69                 Such tumours associated with neurofibromatosis 1 show a loss of neurofibromatosis 1 e
70 ouse model of OPG driven by mutations in the neurofibromatosis 1 tumour suppressor gene (Nf1)(5) to d